{
    "clinical_study": {
        "@rank": "70480", 
        "arm_group": {
            "arm_group_label": "IPBS", 
            "arm_group_type": "Experimental"
        }, 
        "brief_summary": {
            "textblock": "A preliminary demonstration of the Safety of IPBS in positioning a vacuum assisted biopsy\n      (VAB) tool to enable an MRI-guided automated breast biopsy. This will consist of 10-15\n      biopsy procedures facilitated by the MRI-guided system. Patients will be followed after the\n      procedure to assess clinical outcomes."
        }, 
        "brief_title": "Study to Demonstrate the Preliminary Safety and Effectiveness of IPBS in Performing MRI-Guided Targeting and Intervention of Breast Tissue in Female Patients Indicated for MRI-Guided Breast Biopsy", 
        "completion_date": {
            "#text": "September 2015", 
            "@type": "Anticipated"
        }, 
        "condition": [
            "Breast Cancer Screening", 
            "MRI Guided Breast Biopsy", 
            "Breast Cancer Diagnosis"
        ], 
        "condition_browse": {
            "mesh_term": "Breast Neoplasms"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Female patients over the age of 18 with suspected or confirmed breast cancer\n             requiring a manual MRI-guided breast biopsy for diagnosis and staging.\n\n          -  Individuals Capable of giving a free and informed consent.\n\n        Exclusion Criteria:\n\n          -  Any patient for whom the manual MRI-guided breast biopsy procedure would not be\n             possible (size of patient, etc.).\n\n          -  Patients who refuse the procedure for any reason will be excluded from the study at\n             the investigators discretion.\n\n          -  Patients who are not suitable for the procedure will be excluded at the investigators\n             discretion.\n\n          -  Patients unwilling to complete associated study questionnaires or follow up visits.\n\n          -  Women who are pregnant  or who plan to become pregnant within the study duration."
            }, 
            "gender": "Female", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "10", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "June 19, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01885741", 
            "org_study_id": "IPBS-001"
        }, 
        "intervention": {
            "arm_group_label": "IPBS", 
            "intervention_name": "IPBS", 
            "intervention_type": "Device"
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "June 21, 2013", 
        "location": {
            "contact": {
                "email": "nathalie.duchesne@me.com", 
                "last_name": "Nathalie Duchesne, B.Sc., M.D. F.R.C.P.C.", 
                "phone": "418-473-6553"
            }, 
            "facility": {
                "address": {
                    "city": "Quebec City", 
                    "country": "Canada", 
                    "state": "Quebec", 
                    "zip": "G1S 4L8"
                }, 
                "name": "Hopital du Saint-Sacrement"
            }, 
            "investigator": {
                "last_name": "Nathalie Duchesne, MD FRCPC", 
                "role": "Principal Investigator"
            }, 
            "status": "Not yet recruiting"
        }, 
        "location_countries": {
            "country": "Canada"
        }, 
        "number_of_arms": "1", 
        "official_title": "A Prospective, Open-Label, Single-Arm, Single-Site, Study to Demonstrate the Preliminary Safety and Effectiveness of IPBS in Performing MRI-Guided Targeting and Intervention of Breast Tissue in Female Patients Indicated for MRI-Guided Breast Biopsy.", 
        "overall_contact": {
            "email": "anvari@mcmaster.ca", 
            "last_name": "Mehran Anvari, MB PhD FRCS", 
            "phone": "905-522-1155", 
            "phone_ext": "35058"
        }, 
        "overall_contact_backup": {
            "email": "bevanp@mcmaster.ca", 
            "last_name": "Peter Bevan, PhD", 
            "phone": "289-674-0026"
        }, 
        "overall_status": "Not yet recruiting", 
        "oversight_info": {
            "authority": "Canada: Public Health Agency of Canada", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "September 2015", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "Frequency of target reached by the interventional tools as determined by a qualified physician reviewing the MR images.", 
            "safety_issue": "No", 
            "time_frame": "Day 1"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01885741"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "source": "Centre for Surgical Invention and Innovation, Canada", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Centre for Surgical Invention and Innovation, Canada", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "September 2013", 
        "study_design": "Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Diagnostic", 
        "study_type": "Interventional", 
        "verification_date": "June 2013"
    }
}